Long-term remission also possible without DMARDs

Remission without disease-modifying antirheumatic drugs has become an ambitious goal in inflammatory rheumatic diseases. While it has been extensively studied in rheumatoid arthritis, its feasibility in psoriatic arthritis (PsA) has remained largely unclear. Dutch researchers have collected data on prevalence, persistence and prognostic factors.